Phase 3 Trial
The latest news about Phase 3 Trial: headlines, AI summaries and the full story from every source.
- Eli Lilly's Oral GLP-1 Foundayo Shows Significant Improvement in Sleep Apnea Phase 3 Trial
- Bristol Myers Squibb Reports Positive Long-Term Phase 3 Data for Camzyos in Pediatric Patients
- Celcuity Reports Improved Progression-Free Survival with Revtorpyk in Phase 3 Breast Cancer Trial
- AbbVie Reports Strong Phase 3 Results for Myeloma Treatment Etentamig
- Moderna and Merck Report Positive Phase 3 Trial Results for mRNA Cancer Vaccine
- Agenus Shifts Focus to ROBBIN Trial and Secures $85M Financing
- Agenus Announces Shift in Phase 3 Colon-Cancer Strategy and Secures $85 Million Financing
- GSK Partner Hansoh Reports Positive Late-Stage Cancer Trial for Risvutatug Rezetecan
- Intellia Therapeutics' Crispr-based treatment shows success in pivotal trial for hereditary angioedema
- Eli Lilly Seeks FDA Approval for Foundayo in Type 2 Diabetes Patients